3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Lymphoma
138
Lymphoma, Non-Hodgkin
84
Lymphoma, Large B-Cell, Diffuse
83
Small Cell Lung Carcinoma
78
Hodgkin Disease
61
Precursor Cell Lymphoblastic Leukemia-Lymphoma
59
Leukemia
57
Burkitt Lymphoma
56
Lung Neoplasms
49
Lymphoma, Follicular
47
Lymphoma, Mantle-Cell
44
Leukemia, Myeloid, Acute
41
Lymphoma, Large-Cell, Immunoblastic
40
Multiple Myeloma
33
Leukemia, Lymphocytic, Chronic, B-Cell
33
Carcinoma, Non-Small-Cell Lung
30
Recurrence
26
Neuroblastoma
25
Lymphoma, B-Cell, Marginal Zone
25
Central Nervous System Neoplasms
24
Ovarian Neoplasms
18
Sarcoma
17
Brain Neoplasms
17
Dendritic Cell Sarcoma, Interdigitating
16
Congenital Abnormalities
16
Lymphoma, Large-Cell, Anaplastic
15
Breast Neoplasms
15
Testicular Neoplasms
14
Neoplasms, Plasma Cell
14
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Interventions
Temozolomide
2
Sirolimus
2
Irinotecan
2
Bevacizumab
2
tozuleristide
1
etoposide phosphate
1
Stem Cell Transplantation
1
Pregabalin
1
Nivolumab
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Levetiracetam
1
Immunoglobulin G
1
Ginkgo biloba extract
1
Etoposide
1
Donepezil
1
Disulfides
1
Dasatinib
1
Cyclophosphamide
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Pinealoma
×
Etoposide
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled